Government: Page 72


  • Hospital admissions not linked to COVID-19 fell dramatically in fall, especially in Midwest

    The latest analysis from the Kaiser Family Foundation gives a fuller picture of how the pandemic affected inpatient volume throughout 2020, focusing on trends by age, sex and region.

    By Feb. 18, 2021
  • Chiquita Brooks LaSure, reportedly picked to be CMS administrator for President Joe Biden
    Image attribution tooltip
    Retrieved from Manatt on February 18, 2021
    Image attribution tooltip

    Obama admin alum Chiquita Brooks-LaSure picked to head CMS

    Brooks-LaSure will have a lot on her plate. Biden during his campaign ran on expanding the role of the Affordable Care Act and perhaps attempting to build in a public option or lowered Medicare age eligibility.

    By Updated Feb. 19, 2021
  • Image attribution tooltip
    Peter Ashkenaz, ONC
    Image attribution tooltip
    Q&A

    Don Rucker reflects on highs and lows of tenure as ONC head and the future of health IT

    In this exit interview, Rucker, who has been national coordinator since 2017, looked back on his time at the agency and predicted what industry might expect from the Biden administration.

    By Feb. 17, 2021
  • Image attribution tooltip
    Fotolia
    Image attribution tooltip

    One-third of US adults postponed care during pandemic: reports

    Substantial portions of those who delayed or put off services had one or more chronic health conditions, with many reporting health worsened as a result, researchers from the Urban Institute and RWJF found.

    By Ron Shinkman • Feb. 16, 2021
  • Image attribution tooltip
    Adobe Stock
    Image attribution tooltip
    Opinion

    CMS inpatient only policy threatens patient access to appropriate surgical setting

    Nixing Medicare's IPO list has unintended consequences, especially for high-risk patients, the president of the American Academy of Orthopaedic Surgeons argues.

    By Joseph Bosco • Feb. 16, 2021
  • Image attribution tooltip
    Dollar Photo Club
    Image attribution tooltip

    Biden admin begins plan to rescind Medicaid work mandates in win for providers

    The policies threatened to lower hospitals' Medicaid revenues as enrollees lost coverage, raising uncompensated care costs. But lawsuits and the pandemic have kept states from implementing the controversial Trump-era requirements.

    By Feb. 16, 2021
  • A volunteer in a clinical trial is dosed with BNT162, an experimental coronavirus vaccine developed by Pfizer and BioNTech
    Image attribution tooltip
    Permission granted by BioNTech SE
    Image attribution tooltip

    Health system execs: national approach needed to stem vaccine disarray

    "We don't know until we open the package how many doses we're getting that week," EVP of Ascension Joe Cacchione said Thursday during a webinar organized by the American Hospital Association. 

    By Feb. 11, 2021
  • Image attribution tooltip
    Getty
    Image attribution tooltip

    COVID-19 leads to explosion in cyberattacks, data breaches

    A survey from CI Security found successful hacks involving healthcare organizations or their business associates soared in the second half of last year, leading to a jump in the number of breached patient records.

    By Ron Shinkman • Feb. 10, 2021
  • Image attribution tooltip
    Jacob Bell
    Image attribution tooltip

    Visby gets FDA nod for single-use, rapid point-of-care COVID-19 PCR test

    The palm-sized diagnostic gives results in 30 minutes without the need for additional instruments or readers. While Abbott's ID Now provides results in 13 minutes or less, it is the size of a toaster and requires a cartridge.

    By Greg Slabodkin • Feb. 10, 2021
  • As COVID-19 becomes a business, vaccine makers confront thorny pricing questions

    Yearly vaccinations could be required after the pandemic ebbs. Will drugmakers change how they approach pricing their shots?

    By Jonathan Gardner • Feb. 10, 2021
  • Oklahoma selects 4 private payers to manage Medicaid for $2B, faces legal suit

    The state maintains the switch will improve costs while maintaining access, but the move to cede Medicaid control to for-profit entities is highly controversial.

    By Feb. 9, 2021
  • An AstraZeneca scientists involved in vaccine research
    Image attribution tooltip
    Courtesy of AstraZeneca
    Image attribution tooltip

    New data on AstraZeneca vaccine add to worries over coronavirus variant from South Africa

    South Africa will use other shots in its immunization campaign after AstraZeneca's offered "minimal protection" against a coronavirus variant that has spread throughout the country.

    By Ben Fidler • Feb. 8, 2021
  • Pandemic habits could cause US health spending to decelerate over 2 decades, Deloitte predicts

    The consultancy's predictive modeling based its estimate on the rise of digital health products and more consumer engagement. Such a slowing contrasts more dire spending forecasts made prior to the COVID-19 crisis.

    By Feb. 8, 2021
  • Image attribution tooltip
    Adeline Kon/Healthcare Dive
    Image attribution tooltip

    Fitch: Biden's healthcare plans could boost nonprofit hospitals

    The ratings agency cited administration plans to bolster the Affordable Care Act, which could reverse the increased number of uninsured people, as among the factors driving brighter prospects.

    By Ron Shinkman • Feb. 4, 2021
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    J&J asks FDA for emergency clearance of coronavirus vaccine

    The regulator scheduled an advisory committee meeting for Feb. 26, making an authorization by the end of the month possible. 

    By Ned Pagliarulo • Updated Feb. 5, 2021
  • The FDA logo on a glass pane at the agency's campus in Silver Spring, Maryland.
    Image attribution tooltip
    Jacob Bell/Healthcare Dive
    Image attribution tooltip

    FDA appoints first medical device cybersecurity chief

    University of Michigan professor Kevin Fu will serve a one-year term as acting cyber director at the Center for Devices and Radiological Health. Experts fear the chaos of the pandemic creates the perfect storm for hackers to exploit.

    By Greg Slabodkin • Feb. 4, 2021
  • Low Medicare EKG rate a potential setback for device makers

    Wall Street analysts questioned whether the lower-than-expected rates are final and what the prospects are for renegotiation. Shares of market leader iRhythm fell over 32% on Friday.

    By Ricky Zipp • Updated Feb. 1, 2021
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Medicare buy-in for older adults could cut health costs, increase coverage value: Urban Institute

    A Medicare buy-in is not a specific prong of President Joe Biden's health policy agenda, but there are currently two proposals in Congress designed to build upon the ACA.

    By Feb. 3, 2021
  • Image attribution tooltip
    Courtesy of Ellume Health
    Image attribution tooltip

    Biden administration awards $231M to increase US production of at-home, OTC COVID-19 test

    Australian company Ellume will use the funding to establish a U.S. manufacturing facility that is projected to increase production capacity by 640,000 tests per day by December.

    By Susan Kelly • Feb. 2, 2021
  • Image attribution tooltip
    Brian Tucker Industry Dive Image | courtesy of California Office of Attorney General
    Image attribution tooltip

    How might Xavier Becerra operate as HHS Secretary?

    The nominee has made headlines since leaving the House of Representatives, in part by leading blue state efforts to defend the ACA. Less high-profile, perhaps, were his efforts to block major hospital mergers in California.

    By Ron Shinkman • Feb. 1, 2021
  • Colorized scanning electron micrograph of a cell heavily infected with SARS-CoV-2 virus particles, isolated from a patient sample
    Image attribution tooltip
    National Institute of Allergy and Infectious Diseases. (2020). "Novel Coronavirus SARS-CoV-2" [Micrograph]. Retrieved from Flickr.
    Image attribution tooltip

    Vaccine makers prepare response as coronavirus mutations raise alarms

    So far, both Pfizer's and Moderna's vaccines appear to work against more transmissible variants, but preparation is underway for the day they don't.

    By Jonathan Gardner • Feb. 1, 2021
  • An employee of Novavax works on development of a coronavirus vaccine
    Image attribution tooltip
    Courtesy of Novavax
    Image attribution tooltip

    Novavax vaccine prevents COVID-19 in studies, but less effective against new variants

    The drugmaker is already discussing an authorization with health authorities in the U.K., and plans to begin talks with the FDA and other regulators, too.

    By Jonathan Gardner • Jan. 29, 2021
  • Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient.
    Image attribution tooltip
    National Institute of Allergy and Infectious Diseases. (2020). "Novel Coronavirus SARS-CoV-2" [Micrograph]. Retrieved from Flickr.
    Image attribution tooltip

    J&J says single dose of coronavirus vaccine 66% effective in large trial

    The vaccine's efficacy was higher in the U.S., but lower in Latin America and South Africa, where new, more infectious virus variants are circulating.

    By Ned Pagliarulo • Jan. 29, 2021
  • Payers welcome reopening of ACA marketplaces

    Healthcare.gov will be open for a special enrollment period from Feb. 15 through May 15, though advocates say robust outreach and marketing efforts need to be coupled with the move.

    By Jan. 28, 2021
  • Image attribution tooltip
    White House
    Image attribution tooltip

    Biden campaign cyber chief named federal CISO

    Cybersecurity veterans praised the appointment, highlighting Chris DeRusha's extensive government and private sector experience.

    By David Jones • Jan. 28, 2021